Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV ...

Polypharmacy among patients with early RA was associated with lower rates of remission and an increased risk for SAEs over a 10-year period.

New guidance from the American College of Obstetricians and Gynecologists recommends pregnant patients avoid cannabis.

Patients with psoriasis were linked to greater risks for both exudative and nonexudative age-related macular degeneration.

A review recently published in The New England Journal of Medicine detailed the clinical features and major treatment advances in juvenile idiopathic arthritis (JIA) and its specific subtypes: ...

The United States Department of Agriculture recently announced it will no longer publish Household Food Security reports. HealthDay News — For 30 years, Americans have relied on a yearly government ...

Topline data were announced from a phase 3 trial evaluating garetosmab in adults with fibrodysplasia ossificans progressiva.

Patients with gout in the US are at higher risk for chronic opioid exposure, with female sex, greater comorbidity burden, and ULT use identified as risk factors.

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial enrollment.

Complete, but not partial, remission was associated with a lower likelihood of doubling of serum creatinine in patients with pure membranous lupus nephritis.

Multimorbidity was linked to higher odds of disease flare-related visits and lower odds of remission among patients with incident RA.

While colchicine showed efficacy among most patients with SURF, PFAPA-like features were associated with treatment resistance.